ATAI Life Sciences

OverviewSuggest Edit

ATAI Life Sciences is a biotech company that operates a platform dedicated to curing mental health disorders. The Company's initial focus is on developing solutions for people who suffer from depression, a significant unmet medical need. It also invests in and acquires promising therapeutics focusing on longevity and mental wellbeing.

TypePrivate
Founded2018
HQMünchen, DE
Websiteatai.life

Latest Updates

Employees (est.) (Apr 2020)20(+6%)

Key People/Management at ATAI Life Sciences

Florian Brand

Florian Brand

Co-Founder, CEO
Christian Angermayer

Christian Angermayer

Founder
Matthias Luz

Matthias Luz

Chief Medical Officer
Srinivas Rao

Srinivas Rao

Chief Scientific Officer
Show more

ATAI Life Sciences Office Locations

ATAI Life Sciences has an office in München
München, DE (HQ)
Barer Straße 7
Show all (1)

ATAI Life Sciences Financials and Metrics

Summary Metrics

Founding Date

2018

ATAI Life Sciences total Funding

$68 m

ATAI Life Sciences latest funding size

$43 m

Time since last funding

a year ago

ATAI Life Sciences investors

ATAI Life Sciences's latest funding round in March 2019 was reported to be $43 m. In total, ATAI Life Sciences has raised $68 m
Show all financial metrics

ATAI Life Sciences Online and Social Media Presence

Embed Graph

ATAI Life Sciences News and Updates

ATAI Life Sciences Announces Joint Venture with DemeRx to Develop Ibogaine For Opioid Use Disorder

BERLIN and MIAMI, Jan. 24, 2020 /PRNewswire/ -- ATAI Life Sciences AG ("ATAI" or the "Company"), a global biotech platform that envisions an end to mental illnesses, today announced an investment in two separate joint ventures (JV) with DemeRx, a clinical stage pharmaceutical company...

ATAI Life Sciences Blogs

Mental health in a time of COVID-19

Whether you’re on lockdown or just practicing social distancing, chances are you’re beginning to feel the strain. We’re social creatures: We not only desire interaction with others but actually need it. Contact with others — particularly physical contact — triggers neural cascades that release oxyto…

ATAI is courting pharma and biotech investors as it looks to raise millions to turns psychedelics into approved medicines

Florian Brand helped start ATAI Life Sciences with one vision in mind: to effectively treat mental-health disorders by turning psychedelics into medicines.

EntheogeniX Biosciences gets going

Psilocybin, ibogaine, and many other psychedelic substances have yielded remarkable early signals of their efficacy in treating everything from depression to various forms of addiction. And while Dr. Srinivas Rao, Chief Executive Officer of EntheogeniX Biosciences, shares the cautious optimism of ma…

Terence Kelly appointed CEO of ATAI platform company Perception Neuroscience

Today, ATAI Life Sciences, a global biotech platform that envisions an end to mental illnesses, announced the appointment of Dr. Terence Kelly as Chief Executive Officer of Perception Neuroscience, an ATAI biopharmaceutical company developing arketamine for treatment resistant depression. “Terry bri…

Investors are eyeing psychedelics as the next big trend in healthcare as medical-grade treatments inch toward FDA approval

The investor base for companies creating psychedelic drugs can be categorized into three groups, Florian Brand of ATAI Life Sciences said: the visionaries, the "momentum investors," and more recently, pharmaceutical and biotech investors.

ATAI, DemeRx pursue ‘neurochemical reset’ for addiction

ATAI Life Sciences and DemeRx are setting up a joint venture to develop a treatment for opioid dependence that works by giving people a “neurochemical reset.”
Show more

ATAI Life Sciences Frequently Asked Questions

  • When was ATAI Life Sciences founded?

    ATAI Life Sciences was founded in 2018.

  • Who are ATAI Life Sciences key executives?

    ATAI Life Sciences's key executives are Florian Brand, Christian Angermayer and Matthias Luz.

  • How many employees does ATAI Life Sciences have?

    ATAI Life Sciences has 20 employees.

  • Who are ATAI Life Sciences competitors?

    Competitors of ATAI Life Sciences include Phi Therapeutics, Siolta Therapeutics and PamBio.

  • Where is ATAI Life Sciences headquarters?

    ATAI Life Sciences headquarters is located at Barer Straße 7, München.

  • Where are ATAI Life Sciences offices?

    ATAI Life Sciences has an office in München.

  • How many offices does ATAI Life Sciences have?

    ATAI Life Sciences has 1 office.